Monday, 6 June 2022

Urban Remedy recalls strawberry drink after U.S. Hepatitis A outbreak

Urban Remedy recalls strawberry drink after U.S. Hepatitis A outbreak

Urban Remedy has recalled its strawberry hibiscus rose tea drink due to potential contamination with Hepatitis A after an outbreak in organic strawberries that is being investigated by the U.S. Food and Drug Administration.

Uruguay president says COVID-19 positive, will not attend U.S.-hosted Americas Summit

Uruguay President Luis Lacalle Pou said Monday on Twitter that he will not attend the U.S.-hosted Summit of the Americas and was "cancelling all of his activities for the coming days" after testing positive for COVID-19.

Strong T-cell response for blood cancer patients after vaccine; COVID breakthrough often serious for cancer patients

The following is a summary of some recent studies on COVID-19 and cancer presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

U.S. organizes Germany-to-Texas flight with Nestle baby formula

The United States has organized a flight to deliver 110,000 pounds of Nestlé infant formula from Germany to Texas on June 9, the White House said on Monday.

U.S. organizes Germany-to-Texas flight with Nestle baby formula

The United States has organized a flight to deliver 110,000 pounds of Nestlé infant formula from Germany to Texas on June 9, the White House said on Monday.

Becton Dickinson to acquire Parata Systems for over $1 billion

Medical device maker Becton Dickinson and Co said on Monday it would acquire Parata Systems in a $1.52 billion all-cash deal, as it expands into the pharmacy automation sector.

U.S. to get 36,000 more monkeypox vaccine doses this week, HHS says

The Department of Health and Human Services (HHS) said on Monday it had instructed monkeypox vaccine manufacturer Bavarian Nordic to deliver an additional 36,000 doses this week as part of a drawdown from a U.S. vaccine stockpile.

Pfizer to spend $120 mln to boost U.S. COVID pill manufacturing

Pfizer Inc said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up.

Amarin to slash jobs as generic rivals dull U.S. prospects of heart drug

Amarin Corp Plc said on Monday it would cut its workforce by 40%, as the drugmaker's fish-oil derived heart drug faces stiff competition from generic rivals in the United States.

Contract manufacturer Emergent says J&J breached vaccine contract

Contract manufacturer Emergent BioSolutions Inc said on Monday U.S. drugmaker Johnson & Johnson had breached an agreement by failing to buy the minimum quantity of COVID-19 vaccines made by the company.

Related Videos

Monkeypox "will not be like COVID" - Spanish microbiologist

Monkeypox can be contained if we act now: WHO

N.Korea reports more deaths amid COVID lockdown

at